MITF and PU.1 inhibit adipogenesis of ovine primary preadipocytes by restraining C/EBPβ

Abstract

BackgroundPU box-binding protein (PU.1) is a master gene of hematopoietic lineage and an important specific transcription factor in osteoclast lineage. There is proof of its expression in adipose tissue, and it is known to significantly and negatively affect adipogenesis. However, it is unclear whether there are any other molecules involved in this process.MethodsWe wished to explore the effect of PU.1’s co-activator microphthalmia-associated transcription factor (MITF) on the adipogenic differentiation of ovine primary preadipocytes. The expression vectors pcDNA-MITF and pcDNA-PU.1, and MITF siRNA and PU.1 siRNA were transfected or co-transfected into ovine tail primary preadipocytes. Real-time PCR and western blot analysis were applied to investigate the expression levels of PU.1 and MITF. The morphologic changes in the cells were observed under a microscope at a magnification of × 200 after staining with Oil Red O. The triglyceride (TG) content in cells was also determined after transfection.ResultsMITF and its co-activator PU.1 synergistically exhibited an opposite expression pattern to that of CCAAT-enhancer-binding protein-β (C/EBPβ) during adipogenic differentiation of ovine primary preadipocytes. Before induction of differentiation, overexpression of MITF or PU.1 inhibited the expression of C/EBPβ and adipogenesis in the cells; and knockdown of MITF or PU.1 promoted the expression of C/EBPβ and adipogenesis in the cells. The inhibitory or promotive effect was enhanced when MITF and PU.1 were co-overexpressed or co-silenced. However, when MITF and/or PU.1 were overexpressed after day 2 of differentiation, no changes in adipogenesis of the cells were observed.ConclusionsMITF and its co-activator PU.1 inhibited adipogenesis of ovine primary preadipocytes by restraining C/EBPβ.Electronic supplementary materialThe online version of this article (doi:10.1186/s11658-016-0032-y) contains supplementary material, which is available to authorized users.

Adipocyte PU.1 knockout promotes insulin sensitivity in HFD-fed obese mice

“…In previous in vitro based experiments PU.1 has been shown to inhibit adipogenesis 12,17,18 . In agreement with these studies we also observed significantly greater levels of the adipogenic genes Fasn , Acaca , Adipsin , Srebp1c and Scd1 in adipose tissue from PU.1 KO mice compared with fl/fl controls (Fig.…”

“…Because of the improved metabolic phenotype in PU.1 AKO HFD mice, we sought to further examine the role of PU.1 in adipocytes during obesity. Previous in vitro studies have shown that PU.1 inhibits adipocyte differentiation 12,17,18,25,26 . In line with these studies we found PU.1 deletion in adipocytes resulted in increased expression of adipogenic genes (i.e.…”

miR-129 Regulates Yak Intramuscular Preadipocyte Proliferation and Differentiation through the PI3K/AKT Pathway

“…Cell proliferation and differentiation are highly coordinated processes [ 19 ]; therefore, we studied the effects of miR-129 on proliferation during YIMAs differentiation. The scratch results showed that proliferation was significantly altered in the overexpression or inhibition groups compared to their respective controls ( Figure 2 A).…”

PU.1 interacts with KLF7 to suppress differentiation and promote proliferation in chicken preadipocytes

“…Although the interaction between PU.1 and GATA-2 in preadipocytes has not been confirmed, co-expression of PU.1 and GATA-2 further inhibits C / EBPα transcription compared with overexpression of PU.1 or GATA-2 alone, suggesting that PU.1 and GATA-2 inhibit adipocyte differentiation in a synergistic manner [10] . In primary preadipocytes, co-expression of MITF and PU.1 significantly inhibits C / EBPβ expression and adipogenesis, but whether MITF is a coactivator of PU.1 needs further investigation [29] . In addition, miR-191 inhibits preadipocyte differentiation through 3′UTR targeting of C / EBPβ , while PU.1 promotes the expression of miR-191 , thereby inhibiting adipogenesis [30] .…”